Kyle Annen

689 total citations
30 papers, 449 citations indexed

About

Kyle Annen is a scholar working on Infectious Diseases, Hematology and Immunology. According to data from OpenAlex, Kyle Annen has authored 30 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 8 papers in Hematology and 8 papers in Immunology. Recurrent topics in Kyle Annen's work include SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (6 papers) and T-cell and B-cell Immunology (5 papers). Kyle Annen is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (6 papers) and T-cell and B-cell Immunology (5 papers). Kyle Annen collaborates with scholars based in United States, Canada and India. Kyle Annen's co-authors include Duquesnoy Rj, Marilyn Marrari, Paul F. Lindholm, Glenn Ramsey, Vijaya Knight, Thomas E. Morrison, Mary K. McCarthy, Jamil N. Kanji, Carmen Charlton and Ashley Bailey and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

Kyle Annen

27 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kyle Annen United States 10 187 127 81 58 53 30 449
Nancy L. Dock United States 12 116 0.6× 146 1.1× 15 0.2× 114 2.0× 23 0.4× 23 433
Shigeharu Uchida Japan 14 107 0.6× 94 0.7× 8 0.1× 163 2.8× 43 0.8× 45 694
Vincenzo De Angelis Italy 12 106 0.6× 21 0.2× 35 0.4× 85 1.5× 7 0.1× 35 336
Caroline Tinguely Switzerland 12 100 0.5× 138 1.1× 51 0.6× 70 1.2× 25 0.5× 27 520
L Boshkov Canada 9 17 0.1× 77 0.6× 27 0.3× 275 4.7× 90 1.7× 10 748
Elizabeth H. Perry United States 15 100 0.5× 123 1.0× 4 0.0× 266 4.6× 28 0.5× 21 611
Yun Ji Hong South Korea 12 115 0.6× 33 0.3× 10 0.1× 88 1.5× 35 0.7× 48 337
P. Moncharmont France 11 63 0.3× 21 0.2× 8 0.1× 124 2.1× 18 0.3× 39 314
Olufunmilayo Daramola United Kingdom 5 159 0.9× 87 0.7× 5 0.1× 108 1.9× 38 0.7× 6 470
D. Maas Germany 8 22 0.1× 45 0.4× 14 0.2× 70 1.2× 34 0.6× 37 384

Countries citing papers authored by Kyle Annen

Since Specialization
Citations

This map shows the geographic impact of Kyle Annen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle Annen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle Annen more than expected).

Fields of papers citing papers by Kyle Annen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyle Annen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle Annen. The network helps show where Kyle Annen may publish in the future.

Co-authorship network of co-authors of Kyle Annen

This figure shows the co-authorship network connecting the top 25 collaborators of Kyle Annen. A scholar is included among the top collaborators of Kyle Annen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyle Annen. Kyle Annen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Annen, Kyle, Suzanne Arinsburg, Freddy T. Nguyen, et al.. (2025). O blood usage trends in the pediatric population 2015–2019: A multi‐institutional analysis. Transfusion. 65(4). 676–683.
2.
Morgan, Katrina M., Kyle Annen, Stella T. Chou, et al.. (2023). Parent perceptions of emergent blood transfusion in children. Transfusion. 63(S3). S35–S45. 8 indexed citations
3.
Jacquot, Cyril, Oren Gordon, Jeffrey R. Donowitz, et al.. (2023). Multi‐institutional experience with COVID‐19 convalescent plasma in children. Transfusion. 63(5). 918–924.
4.
McKinney, Christopher, et al.. (2022). Chronic granulomatous disease and McLeod syndrome: Stem cell transplant and transfusion support in a 2-year-old patient—a case report. Frontiers in Immunology. 13. 994321–994321. 2 indexed citations
5.
Kelly, Kathleen, et al.. (2022). Cryopreservation of rare pediatric red blood cells for support following bone marrow transplant. Transfusion. 62(5). 954–960. 5 indexed citations
6.
Annen, Kyle, et al.. (2022). Safe peripheral blood stem cell collection in patients less than 10 kg: A single‐center review. Journal of Clinical Apheresis. 38(4). 390–395. 2 indexed citations
7.
Annen, Kyle, et al.. (2021). Presence and short‐term persistence of SARS‐CoV ‐2 neutralizing antibodies in COVID ‐19 convalescent plasma donors. Transfusion. 61(4). 1148–1159. 9 indexed citations
8.
9.
Reppucci, Marina L., Kaci Pickett, Jenny Stevens, et al.. (2021). Massive transfusion in pediatric trauma-does more blood predict mortality?. Journal of Pediatric Surgery. 57(2). 308–313. 11 indexed citations
10.
Merkel, Patricia, Thomas E. Morrison, Mary K. McCarthy, et al.. (2021). Evaluation of a multiplexed coronavirus antigen array for detection of SARS-CoV-2 specific IgG in COVID-19 convalescent plasma. Journal of Immunological Methods. 497. 113104–113104. 2 indexed citations
11.
Schultz, Jonathan, Mary K. McCarthy, Katherine R. Sabourin, et al.. (2021). Development and Validation of a Multiplex Microsphere Immunoassay Using Dried Blood Spots for SARS-CoV-2 Seroprevalence: Application in First Responders in Colorado, USA. Journal of Clinical Microbiology. 59(6). 18 indexed citations
12.
Kuldanek, Susan, et al.. (2021). Cellular Therapy in Pediatric Hematologic Malignancies. Clinics in Laboratory Medicine. 41(1). 121–132. 2 indexed citations
13.
Annen, Kyle, et al.. (2020). Analysis of COVID-19 convalescent plasma for SARS-CoV-2 IgG using two commercial immunoassays. Journal of Immunological Methods. 486. 112837–112837. 16 indexed citations
14.
Annen, Kyle, et al.. (2020). What's in Your CART? Clinical insights on challenges in mononuclear cell collection for CAR‐T therapy. Journal of Clinical Apheresis. 35(3). 234–235. 1 indexed citations
15.
Yassai, Maryam, et al.. (2015). RHCE*cE94G encodes variable expression of c (RH4). Transfusion. 55(10). 2519–2520. 2 indexed citations
16.
Annen, Kyle, et al.. (2015). Optimizing platelet transfusions. Current Opinion in Hematology. 22(6). 559–564. 16 indexed citations
17.
Annen, Kyle, et al.. (2014). The health implications of low hemoglobin deferral in infrequent blood donors. Transfusion. 55(1). 86–90. 8 indexed citations
18.
Annen, Kyle, et al.. (2012). Two Cases of Transfusion-TransmittedAnaplasma phagocytophilum. American Journal of Clinical Pathology. 137(4). 562–565. 41 indexed citations
19.
Lindholm, Paul F., Kyle Annen, & Glenn Ramsey. (2011). Approaches to Minimize Infection Risk in Blood Banking and Transfusion Practice. Infectious Disorders - Drug Targets. 11(1). 45–56. 50 indexed citations
20.
Rj, Duquesnoy, Marilyn Marrari, & Kyle Annen. (1979). Identification of an HLA-DR-associated system of B-cell alloantigens.. PubMed. 11(4). 1757–60. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026